Nature Search

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

ATR/CHK1 pathway inhibitors represent a therapeutic option for platinum-resistant high-grade serous ovarian carcinoma (HGSOC). Here the authors report the results of a phase 2 clinical study of the CHK1 inhibitor prexasertib in patients with BRCA wild-type platinum-resistant HGSOC with or without biopsiable disease.

Elena Giudice
Tzu-Ting Huang
Jung-Min Lee
ResearchOpen Access30 Mar 2024
Nature Communications

Volume: 15, P: 1-14
Author Correction: Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics

Lauren A. Gamble
Paul H. McClelland
Jeremy L. Davis
Amendments and CorrectionsOpen Access23 Oct 2023
npj Breast Cancer

Volume: 9, P: 1-2
Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics

Lauren A. Gamble
Paul H. McClelland
Jeremy L. Davis
ResearchOpen Access27 Sept 2023
npj Breast Cancer

Volume: 9, P: 1-10
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Rebecca J. van Kalsbeek
Melissa M. Hudson
Lisa Zwiers
Amendments and Corrections22 May 2024
Nature Medicine

Volume: 30, P: 2091
Automated abnormality classification of chest radiographs using deep convolutional neural networks

Yu-Xing Tang
You-Bao Tang
Ronald M. Summers
ResearchOpen Access14 May 2020
npj Digital Medicine

Volume: 3, P: 1-8
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Rebecca J. van Kalsbeek
Melissa M. Hudson
Lisa Zwiers
Amendments and Corrections14 Nov 2023
Nature Medicine

Volume: 30, P: 603
Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Rebecca J. van Kalsbeek
Melissa M. Hudson
Lisa Zwiers
Amendments and Corrections13 Dec 2023
Nature Medicine

Volume: 30, P: 605
A joint international consensus statement for measuring quality of survival for patients with childhood cancer

The International Childhood Cancer Outcome Project group, involving survivors and other relevant stakeholders, develop a set of core outcomes to measure the quality of care for 17 types of childhood cancers.

Rebecca J. van Kalsbeek
Melissa M. Hudson
Lisa Zwiers
Reviews15 Jun 2023
Nature Medicine

Volume: 29, P: 1340-1348

Search

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

Author Correction: Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics

Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics

Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Automated abnormality classification of chest radiographs using deep convolutional neural networks

Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer

A joint international consensus statement for measuring quality of survival for patients with childhood cancer

Search

Quick links

Search

Filter By:

Search

Quick links